Abstract
Background COVID-19 has become a global pandemic with a high growth rate of confirmed cases. In Bangladesh, both mortality and affected rates are increasing at an alarming rate.
Therefore, more comprehensive studies of the epidemiological and clinical characteristics of COVID-19 are required to control this pandemic.
Purpose The present study aimed to compare and analyze the sex-specific epidemiological, clinical characteristics, comorbidities, and other information of confirmed COVID-19 patients from the southeast region in Bangladesh for the first time.
Methods 385 lab-confirmed cases were studied out of 2,471 tested samples between 5 June and 10 September 2020. RT-PCR was used for COVID-19 identification and SPSS (version 25) for statistical data analysis.
Results We found that male patients were roughly affected compared to females patients (male 74.30% vs. female 25.7%) with an average age of 34.86 ± 15.442 years, and B (+ve) blood group has been identified as a high-risk factor for COVID-19 infection. Workplace, local market, and bank were signified as sex-specific risk zone (p < 0.001). Pre-existing medical conditions such as diabetes, hypertension, cardiovascular and respiratory diseases were identified among the patients. Less than half of the confirmed COVID-19 cases in the southeast region were asymptomatic (37.73%) and more prevalent among females than males (male vs. female: 36.84% vs. 40.51%, p = 0.001).
Conclusions The findings may help health authorities and the government take necessary steps for identification and isolation, treatment, prevention, and control of this global pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Research Cell, Noakhali Science and Technology University, Bangladesh.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the institutional ethical clearance committee of Noakhali Science and Technology University, Bangladesh (Approval ID: 44-2020).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author affiliations updated
Data Availability
There were various sections in the survey including demographic information, clinical characteristics, pre-existing medical condition, blood group, earlier visited information, vaccination, etc. The investigators were told that their participation was anonymous and entirely voluntary, and there was no reward for taking part. All the participants willingly participated in this work by giving written permission. They were invited to complete the questionnaire. We were present on hand to answer questions or clarify any doubts that they might have. All filled questionnaires were collected by us one by one.
